A total of 289,868 locus tests, based on 28 different protein phenotypes and using one-dimensional electrophoresis to detect variant proteins, has yielded one probable mutation in the offspring of "proximally exposed" parents, who received an estimated average gonadal exposure of 31 to 39 rem in the atomic bombings of Hiroshima and Nagak. There were no mutations in 208,196 locus tests involving children of "distally exposed" parents, who had essentially no radiation exposure. Studies of the genetic effects of atomic bombs have been in progress in Hiroshima and Nagasaki since 1946 (1-5). The first generation of studies was essentially morphological in nature. More recently, profiting from technological developments, studies have been undertaken at the cytogenetic (6, 7) and biochemical (8) levels. We present here a progress report on the results of the biochemical approach at approximately the midpoint of the study. No statistically significant difference between the children of exposed and control parents can be demonstrated at this time (nor was it expected at this juncture in the study). In addition to the timeliness of a progress report, however, the present publication is dictated by three other considerations. (i) The current intense interest in the genetic effects of low-level ionizing radiation has prompted a complete re-evaluation of 30 years of genetic studies on the effects of the atomic bombs; the present data can be integrated into that treatment. (fi) The control aspects of the data of this study can be combined with similar data from other studies to yield a direct estimate of the rate at which spontaneous mutation results in electrophoretic variants of proteins; this should be useful in planning the feasibility and magnitude of any other genetic studies of this type. (Wi) A wealth of data on biochemical variants in Japanese has accumulated during the past 7 years; this description should clear the way for the presentation of this information.
We evaluated the usefulness of the QuantiFERON TB-2G (QFT-2G) test and the tuberculin skin test (TST) in patients with active tuberculosis (TB) disease stratified by age in 10-year increments. Although the positive rate on TST was over 80% in younger patients aged < or =9 years, it decreased to 55% in patients of aged 70-79 years and 33% in patients aged over 80 years. However, the positive rate on QFT-2G test was over 80% for the age groups between 10-19 and 60-69 years, excluding younger patients aged < or =9 years. Furthermore, the rate was 79% in patients aged 70-79 years and 75% in patients over 80 years of age. The positive response rate of the QFT-2G test was significantly higher than that of the TST in patients over 50 years of age. The indeterminate result of the QFT-2G test increased with age and it is suggested that this result is concerned with the severity of underlying diseases in patients with active TB disease. Although the positive rate on QFT-2G test decreased with age in adults, it is thought to be a useful supportive diagnostic method for active TB disease compared to the TST, except in younger patients aged < or =9 years old.
We developed a new, highly sensitive enzymatic method for quantifying creatine in erythrocytes, which comprises creatine amidinohydrolase, sarcosine oxidase, and peroxidase. In the present method, an N-methylcarbamoyl derivative of methylene blue, 10-N-methylcarbamoyl-3,7-bis(dimethylamino)phenothiazine (MCDP), was used as a sensitive chromogenic compound. Potassium ferrocyanide was used to prevent nonspecific oxidation of MCDP. The enzymatic method exhibited good analytical performance: precision, within-run CVs <1.0% and between-day CVs <2.0%; average analytical recovery, 99.3% ± 1.8%; detection limit, 1.0 μmol/L in hemolysate; and linearity, at least up to 500 μmol/L as creatine concentration in hemolysate. Excellent agreement was observed between the present method (y) and HPLC (x), y = 1.029x − 0.002 μmol/g hemoglobin, r = 0.9998, Sy‖x = 0.053 μmol/g hemoglobin (n = 110). No significant interference was produced by various compounds, including guanidino compounds, amino acids, and reducing materials. The reference intervals (mean ± 2 SD) for erythrocyte creatine obtained from 60 males and 60 females were (in μmol/g hemoglobin) 1.18 ± 0.52 (0.66–1.70) for males and 1.35 ± 0.49 (0.86–1.84) for females. Using this method, we documented changes in erythrocyte creatine in patients with various hemolytic conditions, including hemolytic anemia, liver cirrhosis, renal insufficiency, and chronic renal failure treated with hemodialysis with or without the administration of erythropoietin. We conclude that the use of MCDP allows sensitive measurement of erythrocyte creatine and that MCDP with potassium ferrocyanide can improve the sensitivity of assays that use peroxidase for detection of H2O2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.